Ulceration is a common complication of hemangiomas of infancy and presents a therapeutic dilemma for the head and neck–facial plastic surgeon. Multiple therapies are available, further complicating treatment of patients. We review the common characteristics of ulcerated hemangiomas and discuss the treatment modalities available. We present case reports to illustrate management options and a stepwise algorithm for treatment of ulcerated hemangiomas.
Get full access to this article
View all access options for this article.
References
1.
BrucknerAL, FriedenIJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003; 48:477-493. 12664009
2.
AchauerBM, ChangCJ, Vander KamVM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997; 99:1301-1308. 9105356
3.
KimHJ, ColomboM, FreidenIJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol. 2001; 44:962-972. 11369908
4.
WanerM, SuenJY. The natural history of hemangiomas. In: Waner M, Suen JY, ed. Hemangiomas and Vascular Malformations of the Head and Neck. New York, NY: Wiley-Liss; 1999:13-45
5.
LiangMG, FriedenIJ. Perineal and lip ulceration as the presenting manifestation of hemangioma of infancy. Pediatrics. 1997; 99:256-259. 9024458
6.
WanerM, NorthPE, SchererKA, et al.The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003; 139:869-875. 12873881
7.
DavidLR, MalekMM, ArgentaLC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003; 56:317-327. 12873458
8.
EsterlyNB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr. 1996; 26:3-39. 8932511
9.
WeissAH. Adrenal suppression after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol. 1989; 107:518-522. 2540659
10.
MorelliJG, TanOT, WestonWL. Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. AJDC. 1991; 145:1062-1064. 1877568
11.
EzekowitzRA, MullikenJB, FolkmanJ. Interferon alfa-2a for life- threatening hemangiomas of infancy. N Engl J Med. 1992; 326:1456-1463. 1489383
12.
EnjolrasO, BreviereGM, RogerG, et al.Vincristine therapy for function- and life-threatening hemangioma of infancy. Arch Pediatr Adolesc Med. 2004; 11:99-107. 14761730
13.
SugarmanJL, MauroTM, FriedenIJ, et al.Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor. Arch Dermatol. 2002; 138:314-316. 11902979
14.
MetzBJ, RubensteinMC, LevyML, et al.Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol. 2004; 140:867-870. 15262700
15.
DahlMV. Imiquimod: an immune response modifier. J Am Acad Dermatol. 2000;43:S1-S5 0
16.
WelshO, OlazaranZ, GomezM, et al.Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. J Am Acad Dermatol. 2004; 51:639-642. 15389206
